uniQure (0EE0.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0EE0.L in your mock portfolio yet.
uniQure remains unprofitable, as indicated by its negative EPS and PE ratio. The current financial profile suggests ongoing cash burn typical of a clinical‑stage or early commercial biotech, with no clear evidence yet of sustainable profitability.
The stock has shown strong recent momentum, rising 16.9% over the last month and trading far above its 200‑day moving average. The RSI near 70 signals the shares are approaching overbought territory, but the technical setup overall is positive.
Alternative data show modest but mixed signs: hiring is ramping up, while digital audience growth is slow but positive. These signals suggest operational activity and brand presence are stable to improving, but not yet at a scale that would independently justify the sharp stock move.
uniQure’s stock is experiencing a strong technical uptrend despite ongoing losses and negative earnings. The setup reflects a story‑driven biotech rally where expectations for future developments outweigh current fundamentals, leaving the risk/reward balanced between upside optionality and downside if sentiment reverses.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started